| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Neuroscience Graduate Program, Vanderbilt Brain Institute and
2 Department of Pharmacology and Center for Molecular Neuroscience, Vanderbilt University Medical Center, Nashville TN 37232
Presynaptic choline uptake is vital to sustained neuronal acetylcholine (ACh) release; however, only with the recent cloning of choline transporters (CHTs) (i.e., SLC5A7), has a picture emerged of the regulatory pathways supporting CHT modulation. Studies arising from the development of CHT-specific antibodies reveal a large, intracellular reserve of CHT proteins, localized to ACh-containing, synaptic vesicles. The intersection of mechanisms supporting vesicular ACh release and choline uptake demonstrates an elegant mechanism for linking regulation of CHT membrane density to rates of ACh release. Furthermore, these studies point to control of the CHT endocytic process as an important target for novel therapeutics that could offset functional deficits in disorders bearing diminished cholinergic tone, including myasthenias and dementias.
This article has been cited by other articles:
|
|
 |
|
  M. Pinthong, S. A. G. Black, F. M. Ribeiro, C. Pholpramool, S. S. G. Ferguson, and R. J. Rylett Activity and Subcellular Trafficking of the Sodium-Coupled Choline Transporter CHT Is Regulated Acutely by Peroxynitrite Mol. Pharmacol., March 1, 2008; 73(3): 801 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Goodenowe, L. L. Cook, J. Liu, Y. Lu, D. A. Jayasinghe, P. W. K. Ahiahonu, D. Heath, Y. Yamazaki, J. Flax, K. F. Krenitsky, et al. Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia J. Lipid Res., November 1, 2007; 48(11): 2485 - 2498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Mullen, E. A. Mathews, M. H. Vu, J. W. Hunter, D. L. Frisby, A. Duke, K. Grundahl, J. D. Osborne, J. A. Crowell, and J. B. Rand Choline Transport and de novo Choline Synthesis Support Acetylcholine Biosynthesis in Caenorhabditis elegans Cholinergic Neurons Genetics, September 1, 2007; 177(1): 195 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Iwamoto, R. D. Blakely, and L. J. De Felice Na+, Cl-, and pH Dependence of the Human Choline Transporter (hCHT) in Xenopus Oocytes: The Proton Inactivation Hypothesis of hCHT in Synaptic Vesicles J. Neurosci., September 27, 2006; 26(39): 9851 - 9859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Matthies, P. A. Fleming, D. M. Wilkes, and R. D. Blakely The Caenorhabditis elegans choline transporter CHO-1 sustains acetylcholine synthesis and motor function in an activity-dependent manner. J. Neurosci., June 7, 2006; 26(23): 6200 - 6212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Michel, Z. Yuan, S. Ramsubir, and M. Bakovic Choline Transport for Phospholipid Synthesis. Experimental Biology and Medicine, May 1, 2006; 231(5): 490 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Apparsundaram, V. Martinez, V. Parikh, R. Kozak, and M. Sarter Increased Capacity and Density of Choline Transporters Situated in Synaptic Membranes of the Right Medial Prefrontal Cortex of Attentional Task-Performing Rats J. Neurosci., April 13, 2005; 25(15): 3851 - 3856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gates Jr., S. M. Ferguson, R. D. Blakely, and S. Apparsundaram Regulation of Choline Transporter Surface Expression and Phosphorylation by Protein Kinase C and Protein Phosphatase 1/2A J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 536 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Ferguson, M. Bazalakova, V. Savchenko, J. C. Tapia, J. Wright, and R. D. Blakely Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice PNAS, June 8, 2004; 101(23): 8762 - 8767. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ASPET Journals | Pharmacological Reviews | Drug Metabolism and Disposition |
| Molecular Interventions | Molecular Pharmacology | J Pharmacology and Exp Therapeutics |
